These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 31362046)

  • 1. Impact of clinical pharmacist-led interventions on switching from intravenous-to-oral antibiotics in patients with infectious diseases at a Vietnamese hospital.
    Nguyen TNT; Bui QTH; Tran VT; Tran NQ; Nguyen NTY; Nguyen HT; Pham CTL; Pham HTT; Tran MTP; Dau HTT; Nguyen TTT
    Trop Med Int Health; 2023 Aug; 28(8):612-619. PubMed ID: 37387477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunities for Stewardship in the Transition From Intravenous to Enteral Antibiotics in Hospitalized Pediatric Patients.
    Cotter JM; Hall M; Girdwood ST; Stephens JR; Markham JL; Gay JC; Shah SS
    J Hosp Med; 2021 Feb; 16(2):70-76. PubMed ID: 33496660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing IV Antibiotic Duration for Neonatal UTI Using a Clinical Standard Pathway.
    Chang PW; Zhou C; Bryan MA
    Hosp Pediatr; 2024 Jun; 14(6):403-412. PubMed ID: 38708550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing the Use of Enteral Antibiotics in Hospitalized Children With Uncomplicated Infections.
    Molloy MJ; Morris C; Caldwell A; LaChance D; Woeste L; Lenk MA; Brady PW; Schondelmeyer AC
    Pediatrics; 2024 May; 153(6):. PubMed ID: 38712446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalising intravenous to oral antibiotic switch decision making through fair interpretable machine learning.
    Bolton WJ; Wilson R; Gilchrist M; Georgiou P; Holmes A; Rawson TM
    Nat Commun; 2024 Jan; 15(1):506. PubMed ID: 38218885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IV to oral switch: a novel viewpoint.
    Jenkins A
    J Antimicrob Chemother; 2023 Oct; 78(10):2603-2604. PubMed ID: 37549305
    [No Abstract]   [Full Text] [Related]  

  • 7. Physicians' understanding of antibiotic intravenous-to-oral switching-a qualitative study in Suzhou, China.
    Zhang H; Pan J; Hu Z; Pan J; Zhang H
    BMC Health Serv Res; 2024 May; 24(1):686. PubMed ID: 38816777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a sustained, collaborative antimicrobial stewardship programme in spinal cord injury patients.
    Perera D; Vogrin S; Khumra S; Motaganahalli S; Batrouney A; Urbancic K; Devchand M; Mitri E; Clements R; Nunn A; Reynolds G; Trubiano JA
    JAC Antimicrob Resist; 2023 Dec; 5(6):dlad111. PubMed ID: 38021039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Criteria to achieve safe antimicrobial intravenous-to-oral switch in hospitalised adult populations: a systematic rapid review.
    Harvey EJ; McLeod M; De Brún C; Ashiru-Oredope D
    BMJ Open; 2023 Jul; 13(7):e068299. PubMed ID: 37419640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of National Antimicrobial Intravenous-to-Oral Switch Criteria and Decision Aid.
    Harvey EJ; Hand K; Weston D; Ashiru-Oredope D
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical Concerns about the Metrics and Methods of Financial Outcome Measurement in Antimicrobial Stewardship Programs: A Narrative Review.
    Keshavarzi F
    Iran J Med Sci; 2022 Sep; 47(5):394-405. PubMed ID: 36117584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of interactive computerised decision support for hospital antibiotic use (COMPASS): an open-label, cluster-randomised trial in three Swiss hospitals.
    Catho G; Sauser J; Coray V; Da Silva S; Elzi L; Harbarth S; Kaiser L; Marti C; Meyer R; Pagnamenta F; Portela J; Prendki V; Ranzani A; Centemero NS; Stirnemann J; Valotti R; Vernaz N; Suter BW; Bernasconi E; Huttner BD;
    Lancet Infect Dis; 2022 Oct; 22(10):1493-1502. PubMed ID: 35870478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial stewardship using electronic prescribing systems in hospital settings: a scoping review of interventions and outcome measures.
    Jenkins JA; Pontefract SK; Cresswell K; Williams R; Sheikh A; Coleman JJ
    JAC Antimicrob Resist; 2022 Jun; 4(3):dlac063. PubMed ID: 35774070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Multidisciplinary Team Escalating Approach on Antibiotic Stewardship in the United Arab Emirates.
    Sadeq AA; Shamseddine JM; Babiker ZOE; Nsutebu EF; Moukarzel MB; Conway BR; Hasan SS; Conlon-Bingham GM; Aldeyab MA
    Antibiotics (Basel); 2021 Oct; 10(11):. PubMed ID: 34827227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An audit of community-acquired pneumonia antimicrobial compliance using an intervention bundle in an Irish hospital.
    O'Kelly B; Rueda-Benito A; O'Regan M; Finan K
    J Glob Antimicrob Resist; 2020 Dec; 23():38-45. PubMed ID: 32801028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early switching of antibiotic therapy from intravenous to oral using a combination of education, pocket-sized cards and switch advice: A practical intervention resulting in reduced length of hospital stay.
    Mouwen AMA; Dijkstra JA; Jong E; Buijtels PCAM; Pasker-de Jong PCM; Nagtegaal JE
    Int J Antimicrob Agents; 2020 Jan; 55(1):105769. PubMed ID: 31362046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact and barriers of a pharmacist-led practice with computerized reminders on intravenous to oral antibiotic conversion for community-acquired pneumonia inpatients.
    Xu S; Wang X; Song Z; Han F; Zhang C
    J Clin Pharm Ther; 2021 Aug; 46(4):1055-1061. PubMed ID: 34101230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacy-implemented guidelines on switching from intravenous to oral antibiotics: an intervention study.
    McLaughlin CM; Bodasing N; Boyter AC; Fenelon C; Fox JG; Seaton RA
    QJM; 2005 Oct; 98(10):745-52. PubMed ID: 16126741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study.
    Dunn K; O'Reilly A; Silke B; Rogers T; Bergin C
    Int J Clin Pharm; 2011 Apr; 33(2):208-14. PubMed ID: 21744190
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.